Oktoba 28, 2020, SARS-2 Antigen Antigen Gwajin gwajin Nanjing Liming Bio-Products (EUA). Bayan kit ɗin gano SARS-2-2-2 da aka samu da aka samu takardar shaidar Guatemala da takardar shaidar Indonesia FDA, wannan wani babban labari ne na kwarai.

Hoto na 1 wasiƙar Yarda EUA ta yarda

Hoto na 2 Takaddar da aka yi masa rajista na Indonesian na SARS-Cov-2 Antigen Kit

Hoto na 3 Adatemala Takaddun shaida na SARS-Cov-2 Antigen Kit na Gwaji

Idan aka kwatanta da fasahar gano PCR ACC acid, ingancin tantancewa ta zama mafi sauƙin amfani da shi saboda saurin sa da ƙarancin ƙarfi. Don ganowar ƙwayar ƙwayar ƙwayar ƙwayar cuta, taga na Antigen yana da farko, wanda ya fi dacewa da gwajin ƙwararru na farko, kuma shine mai gano nucleic da kuma babban ganowa ga cutarwar ta a asibiti.

Kwatanta da fa'idodin hanyar gano makaman acid da fasahar ganowa:

	RT-PCR Nucleic Acleic acid	Fasahar Antigenologological Vantigen Concection Fasaha
Ji na ƙwarai	Hankali ya wuce 95%. A ka'idar, saboda ganowar acidic na iya fadada samfuran cutar, hankali ya fi na hanyoyin ganowa.	Jin jin daɗin kasancewa daga kashi 60% zuwa 90%, hanyoyin tantancewa suna da tabbataccen kit ɗin ganowa, don haka m na antigen kit ɗin ganowa ne.
BAYANIN	sama da 95%	Fiye da 80%
Gano lokaci-lokaci	Za a iya samun sakamakon gwajin fiye da 2 sa'o'i, kuma saboda kayan aiki da sauran dalilai, a-site dubawa ba za a iya yin su ba.	Samfurin kawai yana buƙatar minti 10-15 don samar da sakamako, wanda za'a iya bincika sauri a shafin.
Ko don amfani da kayan aiki	Yana buƙatar kayan aiki masu tsada kamar su na kayan aikin PCR.	Babu kayan aiki.
Ko aiki guda	A'a, duk suna duk samfuran ne.	Iya.
Matsalar ta fasaha	Hadaddun da bukatar kwararru.	Sauki da sauki aiki.
Harkar sufuri da yanayin ajiya	Sufuri da shagon a debe 20 ℃.	Zazzabi daki.
Farashin sake	Tsada.	Arha.

Gwajin COV-2 2 Antigen Rapid

SARS-Cov-2 Antigen Kit